200 related articles for article (PubMed ID: 38640338)
1. Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis.
Jin D; Qian L; Chen J; Yu Z; Dong J
Medicine (Baltimore); 2024 Apr; 103(16):e37834. PubMed ID: 38640338
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
Ding W; Tan Y; Qian Y; Xue W; Wang Y; Jiang P; Xu X
PLoS One; 2019; 14(10):e0223971. PubMed ID: 31618252
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
4. Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Li XS; Li JW; Li H; Jiang T
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32255189
[TBL] [Abstract][Full Text] [Related]
5. The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis.
Qi YQ; Xiong F; Chen YJ
Pathol Res Pract; 2023 Dec; 252():154919. PubMed ID: 37939428
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis.
Ding W; Xu X; Qian Y; Xue W; Wang Y; Du J; Jin L; Tan Y
Medicine (Baltimore); 2018 Dec; 97(50):e13301. PubMed ID: 30557978
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients.
Yi B; Cheng Y; Chang R; Zhou W; Tang H; Gao Y; Zhang C
Biosci Rep; 2023 Feb; 43(2):. PubMed ID: 36633963
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
Xu X; Tan Y; Qian Y; Xue W; Wang Y; Du J; Jin L; Ding W
Medicine (Baltimore); 2019 Jan; 98(2):e13923. PubMed ID: 30633166
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Zhang Y; Li Y; Jiang W; Li Q; Lan Y
Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis.
Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T
Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Sun T; Li P; Sun D; Bu Q; Li G
Medicine (Baltimore); 2018 Oct; 97(43):e12954. PubMed ID: 30412113
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Qi X; Li J; Deng H; Li H; Su C; Guo X
Oncotarget; 2016 Jul; 7(29):45283-45301. PubMed ID: 27304193
[TBL] [Abstract][Full Text] [Related]
18. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
Hu L; Lin J; Wang A; Shi X; Qiao Y
World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
20. The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Pang Q; Qu K; Zhang JY; Song SD; Liu SS; Tai MH; Liu HC; Liu C
Medicine (Baltimore); 2015 Sep; 94(37):e1431. PubMed ID: 26376382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]